Enovix Target of Unusually Large Options Trading (NASDAQ:ENVX)

Enovix Co. (NASDAQ:ENVXGet Free Report) was the recipient of unusually large options trading on Thursday. Traders acquired 41,377 call options on the stock. This is an increase of 21% compared to the typical volume of 34,227 call options.

Enovix Stock Down 14.1 %

Shares of NASDAQ:ENVX opened at $9.01 on Friday. The firm has a fifty day moving average price of $10.06 and a two-hundred day moving average price of $11.05. The company has a market cap of $1.59 billion, a price-to-earnings ratio of -5.59 and a beta of 1.98. The company has a debt-to-equity ratio of 0.97, a current ratio of 3.98 and a quick ratio of 3.84. Enovix has a one year low of $5.70 and a one year high of $18.68.

Enovix (NASDAQ:ENVXGet Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.03. Enovix had a negative return on equity of 91.21% and a negative net margin of 1,434.34%. The firm had revenue of $4.30 million for the quarter, compared to analysts’ expectations of $4.11 million. During the same quarter last year, the firm posted ($0.27) EPS. Analysts anticipate that Enovix will post -1.2 EPS for the current fiscal year.

Insider Transactions at Enovix

In related news, insider Arthi Chakravarthy sold 35,000 shares of the company’s stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $13.00, for a total value of $455,000.00. Following the sale, the insider now owns 343,305 shares in the company, valued at $4,462,965. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 15.70% of the company’s stock.

Hedge Funds Weigh In On Enovix

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in Enovix by 1.3% in the first quarter. Vanguard Group Inc. now owns 13,093,710 shares of the company’s stock worth $104,881,000 after acquiring an additional 164,717 shares in the last quarter. Driehaus Capital Management LLC boosted its stake in Enovix by 63.7% in the second quarter. Driehaus Capital Management LLC now owns 3,886,492 shares of the company’s stock worth $60,085,000 after buying an additional 1,512,424 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Enovix by 2,228.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,438,011 shares of the company’s stock valued at $11,518,000 after acquiring an additional 1,376,253 shares during the last quarter. Masters Capital Management LLC raised its stake in shares of Enovix by 3.8% during the first quarter. Masters Capital Management LLC now owns 1,350,000 shares of the company’s stock worth $10,814,000 after acquiring an additional 50,000 shares in the last quarter. Finally, Old West Investment Management LLC boosted its stake in shares of Enovix by 12.3% in the 3rd quarter. Old West Investment Management LLC now owns 937,838 shares of the company’s stock valued at $8,759,000 after purchasing an additional 102,452 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on ENVX shares. Janney Montgomery Scott downgraded shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a research report on Thursday. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $30.00 target price on shares of Enovix in a report on Wednesday. JPMorgan Chase & Co. dropped their price target on Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. TD Cowen boosted their price objective on Enovix from $11.00 to $14.00 and gave the stock a “hold” rating in a research report on Thursday, August 1st. Finally, Canaccord Genuity Group raised their target price on Enovix from $17.00 to $20.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $20.50.

Get Our Latest Analysis on Enovix

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.